目的 :探讨克拉瑞啶治疗缺血性脑卒中的临床效果。方法 :选择经临床、头颅CT和 /或MRI确诊的 60例急性缺血性脑卒中患者 ,随机分为 2组。治疗组与对照组分别给予克拉瑞啶 160mg及川芎嗪 12 0mg ,均加入5 0 0ml低分子右旋糖酐中静点 ,qd ,连用 2周。 结果 :治疗组患者用药后神经功能缺损评分减少及总的生活能力有明显提高 (P <0 .0 0 1) ;血小板聚集率及血浆粘度有明显下降 (P <0 .0 1) ;两组患者总的疗效有明显差异 (P <0 .0 0 5 )。结论 :克拉瑞啶对急性缺血性脑卒中有较好疗效 ,尤其可作为轻型或中型患者急性期应用 Objective: To investigate the clinical effect of clarithromycin in the treatment of ischemic stroke. Methods: Sixty patients with acute ischemic stroke confirmed by clinical, head CT and / or MRI were randomly divided into two groups. Treatment group and control group were given clarithromycin 160mg and tetramethylpyrazine 120mg, were added low molecular weight dextran 500ml, qd, once every 2 weeks. Results: After treatment, the neurological deficit scores and the total living ability of the patients in the treatment group decreased significantly (P <0.01); the platelet aggregation rate and plasma viscosity decreased significantly (P <0.01); both groups The overall efficacy of the patients was significantly different (P <0.05). Conclusion: Clariidine has a good curative effect on acute ischemic stroke, especially as acute or mild type of patients